Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade

Scand J Rheumatol. 2011;40(5):400-1. doi: 10.3109/03009742.2011.599072.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / epidemiology*
  • Bronchoalveolar Lavage Fluid / cytology
  • Drug Therapy, Combination
  • Dyspnea / drug therapy
  • Female
  • Humans
  • Isoxazoles / therapeutic use
  • Leflunomide
  • Lung Diseases, Interstitial / diagnostic imaging
  • Lung Diseases, Interstitial / drug therapy*
  • Lung Diseases, Interstitial / epidemiology*
  • Methotrexate / therapeutic use
  • Middle Aged
  • Peptides, Cyclic / antagonists & inhibitors
  • Peptides, Cyclic / blood
  • Peptides, Cyclic / immunology
  • Radiography
  • Receptors, Interleukin-6 / antagonists & inhibitors*
  • Rheumatoid Factor / blood
  • Steroids / therapeutic use

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Isoxazoles
  • Peptides, Cyclic
  • Receptors, Interleukin-6
  • Steroids
  • cyclic citrullinated peptide
  • Rheumatoid Factor
  • Leflunomide
  • tocilizumab
  • Methotrexate